You have a right to know why a health insurer denied your claim
US health insurance claim denials are portrayed as opaque, error-prone, and often driven by cost-cutting incentives that override doctors’ recommendations and patients’ needs. Commenters share stories of pre-approved treatments later denied, automated mass rejections reviewed in seconds, and complex appeals that require insider knowledge or legal action, while others note that employers, regulators, and fraud prevention pressures also shape these practices. Many see incremental transparency reforms (like the right to see claim files) as helpful but ultimately inadequate without deeper structural changes to how healthcare is financed and rationed.
Denial reasons and transparency
- Many see knowing “why” a claim was denied as hollow, since justifications can be opaque code or policy designed to obscure cost-cutting.
- Others argue access to the full claims file is still valuable: it exposes human errors, mis-coding, and contradictions with the insurer’s own rules and can strengthen appeals.
- Some note that people often don’t even know a denial occurred, or get billed months later, adding to confusion.
Human error vs. systemic abuse
- Examples show clear mistakes (wrong drug formulation, miscoding “routine” vs. urgent) and obvious pattern abuse (all claims denied before a date, all approved after).
- There’s debate whether most denials are accidental, necessary cost control, or deliberate profit-seeking; commenters present all three views.
- Several cite investigative reporting about ultra-fast, rubber‑stamp denials (e.g., “1.2 seconds per case”) as evidence of systemic bad faith.
Doctors vs. insurers
- Physicians describe pre-authorization and step therapy as demoralizing, delaying care, and second‑guessing clinical judgment.
- Some industry‑savvy commenters say pre‑auth and coverage rules exist to prevent waste/fraud and ration finite resources; critics call this “death panels.”
- There’s concern that non‑practicing or out‑of‑specialty doctors (or non‑doctors) effectively “practice medicine” by denying care.
Insurer incentives and structure
- One side emphasizes ACA medical loss ratio rules and self‑insured employers: insurers allegedly make thin margins and often just administer employer‑driven cost controls.
- Others counter with insurer revenue/profit growth and cases of claim‑denial schemes or upcoding in Medicare Advantage, arguing profit motives clearly drive behavior.
- Some highlight vertical integration (PBMs, owned providers) as a way to game regulations.
Patient strategies and legal angles
- Tactics: repeated resubmission, detailed appeals with CPT/NDC codes, leveraging doctors’ offices, small‑claims lawsuits, and public shaming (e.g., LinkedIn).
- A few suggest structural fixes: requiring named doctors to originate denials, personal/professional liability for harmful denials, mandated disclosure of denial and appeal statistics, or national treatment guidelines.
- ERISA and employer‑provided plans are noted as legally shielding insurers and limiting patient recourse.
Broader systemic critique
- Many see US healthcare as a uniquely dystopian, inelastic-demand market where profit extraction, lobbying, and corruption dominate.
- Single‑payer or universal models are frequently endorsed; others stress that all systems ration care and struggle with cost, fraud, and limited resources.
- Several non‑US readers contrast simpler public systems (e.g., low or zero out‑of‑pocket for major illness) with US complexity and cognitive burden.